AC Immune (ACIU) Tax Provisions (2022 - 2023)
AC Immune's (ACIU) quarterly Tax Provisions came in at -$1127.4 in Q4 2023, up 45.7% year-on-year from -$773.77 in Q4 2022, and up 66.81% on a QoQ basis from -$3396.5 in Q3 2023.
AC Immune (ACIU) Tax Provisions (2022 - 2023) Analysis & Trends
AC Immune (ACIU) has 2 years of Tax Provisions data on file, last reported at -$1127.4 in Q4 2023.
- On a quarterly basis, Tax Provisions rose 45.7% year-over-year to -$1127.4 in Q4 2023; TTM through Dec 2023 was -$11103.8, a 18.74% increase from a year earlier, with the FY2024 full-year figure at -$3424.6, up 69.62% from the prior year.
- Tax Provisions for Q4 2023 stood at -$1127.4, up from -$3396.5 in the prior quarter.
- Over the last five years, Tax Provisions for ACIU reached as high as -$1127.4 in Q4 2023 and fell as low as -$4331.2 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | AC Immune | 222.66 Mn | 222.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -1,127.35 |
| Sep 30, 2023 | -3,396.46 |
| Jun 30, 2023 | -3,336.53 |
| Mar 31, 2023 | -3,243.49 |
| Dec 31, 2022 | -2,076.04 |
| Sep 30, 2022 | -4,141.83 |
| Jun 30, 2022 | -3,114.88 |
| Mar 31, 2022 | -4,331.23 |